...
search icon
sngx-img

Soligenix Inc. Share Price

SNGX
NAQ
$1.09
-$0.02
(-1.8%)
1D
Industry: Biotechnology Sector: Health Care

Soligenix Inc. Analyst Forecast

Soligenix Inc. Share Price Chart

Soligenix Inc. Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$11.20M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
161.69K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.01
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.02 L
$6.23 H
$1.09

About Soligenix Inc., Common Stock

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. It operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the treatment of cutaneous T-cell lymphoma; SGX942, an innate defense regulator (IDR) technology that is in Phase 3 clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer; SGX945, an IDR technology that is in Phase 2a study to treat aphthous ulcers in Behçet's disease; and SGX302, an IDR technology, which is in Phase 2a study for the treatment of mild-to-moderate psoriasis. Its Public Health Solutions segment engages in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase 1a, 1b, and 1c clinical trials; SGX943, a therapeutic candidate in preclinical studies for the treatment of antibiotic-resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; CiVax, a vaccine candidate for the prevention of COVID-19; and vaccine programs that target filoviruses, such as Marburg and Ebola. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in September 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey. more

Industry: BiotechnologySector: Health Care

Soligenix Inc. Stock Returns

Time FrameSNGXSectorS&P500
1-Week Return0.93%0.72%-1.31%
1-Month Return-21.01%1.27%0.78%
3-Month Return-20.44%3.13%3.46%
6-Month Return-78.02%15.81%6.19%
1-Year Return-55.33%8.89%11.68%
3-Year Return-98.34%20.79%71.21%
5-Year Return-99.77%35.89%74.81%
10-Year Return-99.95%138.44%256.59%

Soligenix Inc. Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue1.93M33.35K250.00K839.36K119.37K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":1.73,"profit":true},{"date":"2022-12-31","value":12.95,"profit":true},{"date":"2023-12-31","value":43.48,"profit":true},{"date":"2024-12-31","value":6.18,"profit":true}]
Cost of Revenue1.82M728.64K550.82K742.05K119.37K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":40.01,"profit":true},{"date":"2022-12-31","value":30.25,"profit":true},{"date":"2023-12-31","value":40.75,"profit":true},{"date":"2024-12-31","value":6.56,"profit":true}]
Gross Profit109.58K(695.29K)(300.82K)(742.05K)(119.37K)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-634.48,"profit":false},{"date":"2022-12-31","value":-274.51,"profit":false},{"date":"2023-12-31","value":-677.15,"profit":false},{"date":"2024-12-31","value":-108.93,"profit":false}]
Gross Margin5.68%(2084.76%)(120.33%)(88.41%)(100.00%)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-36727.1,"profit":false},{"date":"2022-12-31","value":-2119.82,"profit":false},{"date":"2023-12-31","value":-1557.45,"profit":false},{"date":"2024-12-31","value":-1761.69,"profit":false}]
Operating Expenses18.70M12.40M13.94M6.96M9.32M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":66.34,"profit":true},{"date":"2022-12-31","value":74.55,"profit":true},{"date":"2023-12-31","value":37.21,"profit":true},{"date":"2024-12-31","value":49.85,"profit":true}]
Operating Income(18.59M)(13.10M)(14.24M)(7.70M)(9.44M)[{"date":"2020-12-31","value":-1858650700,"profit":false},{"date":"2021-12-31","value":-1309896000,"profit":false},{"date":"2022-12-31","value":-1423890400,"profit":false},{"date":"2023-12-31","value":-769794000,"profit":false},{"date":"2024-12-31","value":-943949700,"profit":false}]
Total Non-Operating Income/Expense50.21K(1.18M)(1.54M)(488.83K)977.78K[{"date":"2020-12-31","value":5.14,"profit":true},{"date":"2021-12-31","value":-120.61,"profit":false},{"date":"2022-12-31","value":-157.19,"profit":false},{"date":"2023-12-31","value":-49.99,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(18.53M)(13.42M)(14.95M)(7.91M)(8.68M)[{"date":"2020-12-31","value":-1852541500,"profit":false},{"date":"2021-12-31","value":-1341571500,"profit":false},{"date":"2022-12-31","value":-1495327400,"profit":false},{"date":"2023-12-31","value":-790853300,"profit":false},{"date":"2024-12-31","value":-867569000,"profit":false}]
Income Taxes(836.89K)(864.74K)(1.15M)(1.77M)(409.11K)[{"date":"2020-12-31","value":-83689300,"profit":false},{"date":"2021-12-31","value":-86474200,"profit":false},{"date":"2022-12-31","value":-115493500,"profit":false},{"date":"2023-12-31","value":-176780300,"profit":false},{"date":"2024-12-31","value":-40911400,"profit":false}]
Income After Taxes(17.69M)(12.55M)(13.80M)(6.14M)(8.27M)[{"date":"2020-12-31","value":-1768852200,"profit":false},{"date":"2021-12-31","value":-1255097300,"profit":false},{"date":"2022-12-31","value":-1379833900,"profit":false},{"date":"2023-12-31","value":-614073000,"profit":false},{"date":"2024-12-31","value":-826657600,"profit":false}]
Income From Continuous Operations(17.69M)(12.55M)(13.80M)(8.07M)(8.27M)[{"date":"2020-12-31","value":-1768852200,"profit":false},{"date":"2021-12-31","value":-1255097300,"profit":false},{"date":"2022-12-31","value":-1379833900,"profit":false},{"date":"2023-12-31","value":-807439000,"profit":false},{"date":"2024-12-31","value":-826657600,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(17.69M)(12.55M)(13.80M)(6.14M)(8.27M)[{"date":"2020-12-31","value":-1768852200,"profit":false},{"date":"2021-12-31","value":-1255097300,"profit":false},{"date":"2022-12-31","value":-1379833900,"profit":false},{"date":"2023-12-31","value":-614073000,"profit":false},{"date":"2024-12-31","value":-826657600,"profit":false}]
EPS (Diluted)(9.60)(4.65)(8.18)(0.97)(3.41)[{"date":"2020-12-31","value":-960,"profit":false},{"date":"2021-12-31","value":-465,"profit":false},{"date":"2022-12-31","value":-818,"profit":false},{"date":"2023-12-31","value":-97,"profit":false},{"date":"2024-12-31","value":-341,"profit":false}]

Soligenix Inc. Ratios

Soligenix Inc. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

SNGX
Cash Ratio 3.08
Current Ratio 3.18

Soligenix Inc. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SNGX
ROA (LTM) -69.38%
ROE (LTM) -165.10%

Soligenix Inc. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SNGX
Debt Ratio Lower is generally better. Negative is bad. 0.33
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.67

Soligenix Inc. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SNGX
Trailing PE NM
Forward PE NM
P/S (TTM) 3874.85
P/B 1.46
Price/FCF NM
EV/R 1.87
EV/Ebitda NM
PEG NM

FAQs

What is Soligenix Inc. share price today?

Soligenix Inc. (SNGX) share price today is $1.09

Can Indians buy Soligenix Inc. shares?

Yes, Indians can buy shares of Soligenix Inc. (SNGX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SNGX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Soligenix Inc. be purchased?

Yes, you can purchase fractional shares of Soligenix Inc. (SNGX) via the Vested app. You can start investing in Soligenix Inc. (SNGX) with a minimum investment of $1.

How to invest in Soligenix Inc. shares from India?

You can invest in shares of Soligenix Inc. (SNGX) via Vested in three simple steps:

  • Click on Sign Up or Invest in SNGX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Soligenix Inc. shares
What is Soligenix Inc. 52-week high and low stock price?

The 52-week high price of Soligenix Inc. (SNGX) is $6.23. The 52-week low price of Soligenix Inc. (SNGX) is $1.02.

What is Soligenix Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Soligenix Inc. (SNGX) is

What is Soligenix Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Soligenix Inc. (SNGX) is 1.46

What is Soligenix Inc. dividend yield?

The dividend yield of Soligenix Inc. (SNGX) is 0.00%

What is the Market Cap of Soligenix Inc.?

The market capitalization of Soligenix Inc. (SNGX) is $11.20M

What is Soligenix Inc.'s stock symbol?

The stock symbol (or ticker) of Soligenix Inc. is SNGX

How Can Investors Use Soligenix Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of Soligenix Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Soligenix Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Soligenix Inc. shares for Indian investors?

When investing in Soligenix Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Soligenix Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Soligenix Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of Soligenix Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Soligenix Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top